Dermatology & Plastic Surgery Institute Outcomes
Brain Tumors
Stereotactic Radiosurgery: Gamma Knife
Both the 30- and 180-day survival rates for Gamma Knife® radiosurgery were 100% for 2022; 883 Gamma Knife procedures were done.
Gamma Knife Radiosurgery: Survival by Tumor Type – Meningioma
2018 – 2022
Both the 30- and 180-day survival rates after Gamma Knife radiosurgery for meningioma in 2022 were 100%.
Gamma Knife Radiosurgery: Survival by Tumor Type – Schwannoma
2018 – 2022
Both the 30- and 180-day survival rates after Gamma Knife radiosurgery for Schwannoma in 2022 were 100%.
Gamma Knife Radiosurgery: Survival by Tumor Type – Pituitary
2018 – 2022
Both the 30- and 180-day survival rates after Gamma Knife radiosurgery for pituitary tumors in 2022 were 100%.
Gamma Knife Radiosurgery: Survival by Tumor Type – Metastasis
2018 – 2022
The 30- and 180-day survival rates after Gamma Knife radiosurgery for brain metastasis were 100% in 2022.
Survival: Gamma Knife Stereotactic Radiosurgery
2018 – 2022
The 30- and 180-day survival rates after Gamma Knife radiosurgery were 100% for 2022; 883 Gamma Knife procedures were done.
